1. Genomics and brain-tumour drug resistance ReviewGenomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours? Markus Bredel,…

Slide 1 NSABP PROTOCOL C-10: RESULTS A Phase II Trial of 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) Plus Bevacizumab for Patients with Unresectable Stage IV Colon…

Slide 1 BCIRG006 - Randomized Phase III Trial Comparing AC-T vs AC-TH vs TCH in HER2 Positive Node Positive or High Risk Node Negative Breast Cancer Initial efficacy from…

Slide 1 Issues of Mitosis “The Life and Times of the Cell” Slide 2 Summary of Mitosis Mitosis Prophase: Replicated chromatin condense into chromatid pair Centrioles move…

Identifying Tumors Expressing Predictive Markers: Lessons Learned From HER2 Dennis J. Slamon, MD, PhD TRIO Chairman Chief, Division of Hematology/Oncology David Geffen School…

ANTI-TUBERCULOSIS DRUGS ANTI-TUBERCULOSIS DRUGS Tuberculosis (TB) is a disease that has affected mankind for centuries and dates as far back as ancient Egyptian times. is…

ANTI-TUBERCULOSIS DRUGS ANTI-TUBERCULOSIS DRUGS Tuberculosis (TB) is a disease that has affected mankind for centuries and dates as far back as ancient Egyptian times. is…